Mild cases were treated with SGLT2-inhibitors such as JARDIANCE (empagliflozin) to reduce proteinuria, and ACE-inhibitors such as COVERSYL (perindopril) were administered to lower blood pressure and slow the progression of kidney disease [37,38]. The gene discussed is SLC5A2; the disease is kidney disorder.